Medical robotics company, CUREXO, Inc., has received EEA CE marking for its in-house developed artificial surgical robot, CUVIS-joint.
CUVIS-joint was MFDS certified in June of last year and was provided to domestic general hospitals, orthopedic hospitals, and even Meril Life Sciences Pvt. Ltd., India.
In early March, Sakra World Hospital carried out 100 successful Total Knee replacement surgeries with the Meril-CUVIS joint Robotics system and is carrying out 10 operations on a weekly basis. Additionally, followed by Sakra World Hospital, SAI hospital (second in India) is in preparation for operations as CUVIS-joint will be supplied.
CUREXO, with the CE marking, will be able to expand its market across Europe, Australia, and parts of Asia as it has done in the previous year in the domestic and Indian markets. They have their eyes set on obtaining FDA approval in order to further expand its global market.
CEO, Jaejun Lee, said, “We are happy to see that we were approved for the CE marking earlier than we expected. We anticipated approval to take place in the second quarter of the year.” He continued, “We plan on promoting partnerships with implant and medical enterprises in Europe and proceed to signing agreements. Also, we expect a positive outcome for our expansion into the global market in 2021 with our early approval.”